SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter & Gamble Health informs about change in senior management personnel

11 Jun 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirement) Regulations, 2015, Procter & Gamble Health has informed that Siddhartha Vachaspati, shall cease to be Company’s Sales Leader effective June 30, 2025, as he is leaving the Company to pursue other interests outside the Company. A copy of letter from Vachaspati is enclosed.

The above information is a part of company’s filings submitted to BSE.

Procter&Gamble Healt Share Price

5150.25 -44.30 (-0.85%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.10
Dr. Reddys Lab 1287.95
Cipla 1334.85
Zydus Lifesciences 901.65
Lupin 2350.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×